Avoro Capital Advisors LLC Ocular Therapeutix, Inc Transaction History
Avoro Capital Advisors LLC
- $5.48 Billion
- Q2 2025
A detailed history of Avoro Capital Advisors LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 7,400,000 shares of OCUL stock, worth $92.4 Million. This represents 1.25% of its overall portfolio holdings.
Number of Shares
7,400,000
Previous 8,060,000
8.19%
Holding current value
$92.4 Million
Previous $59.1 Million
16.24%
% of portfolio
1.25%
Previous 0.96%
Shares
3 transactions
Others Institutions Holding OCUL
# of Institutions
202Shares Held
137MCall Options Held
743KPut Options Held
321K-
Deep Track Capital, LP Greenwich, CT14.3MShares$178 Million4.71% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$173 Million98.75% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$159 Million23.46% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$144 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$105 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $961M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...